Similarly, SLC11A1, referred to as natural resistance-associated macrophage protein 1 (NRAMP1), is associated with poor prognosis and resistance to immunotherapy in CRC, and serves as a valuable biomarker for predicting OS of CRC patients (40, 41). This evidence concerns the gene SLC11A1 and colorectal carcinoma.